Cancer Genetics
USC Center Testing Efficacy of Colorectal Cancer, Genetic Risk Education in Hispanic Community
Premium
In the trial, researchers will evaluate whether educational materials and talks increase knowledge and healthy lifestyles among community members.
Machine Learning Cancer Prognostic Tool Identifies MYC Gain as Glioma Drug Resistance Marker
Premium
The open-source CELLO2 algorithm helped identify a subset of glioma patients at high risk for developing resistance to Merck's Temodar (temozolomide).
Wren Labs Launches Neuroendocrine Tumor Liquid Biopsy in Asia, Works on Expanding Testing Menu
Premium
The Branford, Connecticut-based company is preparing to launch a prostate cancer liquid biopsy test while in early discussions to expand its existing test into Japan.
Pharmacotyping Links Childhood Leukemia Subtypes to Treatment Response
With drug sensitivity and genomic profiles on acute lymphoblastic leukemia cells, coupled with patient data, researchers saw pharmacotypes related to treatment response and outcomes.
Autoantibody Test Shows It Can Predict Toxicity, Recurrence in Melanoma Patients on Immunotherapy
Premium
NYU researchers want to commercialize an LDT based on data that shows an autoantibody signature has dual capabilities.